Wild-type p53 is a short-lived nuclear phosphoprotein coded by the p53 tumour suppressor gene located on chromosome 17p 13. Its main function is to downregulate the cell cycle reducing the mutagenic effects of DNA damage hence preventing carcinogenesis.>5
Mutational change of the p53 gene is the commonest abnormality detected in human malignant neoplasia resulting in loss of action of the p53 gene. The p53 protein product of the altered gene becomes stable and easily detectable immunohistochemically. Mechanisms of p53 overexpression without p53 gene mutations have also been reported.6
Invasive squamous cell carcinoma (SCC) of the larynx is a common malignancy and tobacco, alcohol, human papilloma viruses (HPV), and malnutrition have all been implicated as aetiological factors in laryngeal carcinogenesis although their mode of action is not clear. region.'22' It seems that the mutated p53 gene plays a significant role in the early stages of carcinogenesis and may determine progression of the disease during the late stages of tumour development. 17 22 Greek patients with laryngeal SCC are usually heavy smokers and the present study was undertaken to assess p53 expression during the sequential steps of laryngeal carcinogenesis as very few studies refer to this phenomenon. 17 
Methods
Archival paraffin wax embedded sections of laryngeal biopsy or laryngectomy specimens fixed in neutral buffer formol were studied retrospectively, using immunohistochemical methods. The length of fixation was unknown for the laryngectomy specimens but the laryngeal biopsy specimens were fixed for up to 24 hours. The study population comprised 83 patients in total, including 41 with laryngeal invasive SCC, 28 cases of mild (n= 10), moderate (n = 8) or severe (n = 10) dysplasia without associated invasive malignancy, and a control group of laryngeal nodules (14 cases) without evidence of malignancy despite a history of heavy smoking (10 of 14 cases). Heavy smokers (group A) were patients who smoked more than 20 cigarettes daily for at least five years, patients in group B smoked less than 20 cigarettes daily and those in group C were non-smokers. The clinicopathological features of all patients are indicated in table 1.
The microwave postfixation Streptavidin/ horseradish peroxidase method was applied to paraffin wax sections (5-6 jm)2324 which were then incubated with the two monoclonal anti- comparable for both monoclonal antibodies but there was a slight increase in sensitivity with D07 (three cases negative with 1801 were positive with D07). The staining intensity within individual cases varied from area to area, particularly in the laryngectomy specimen sections. In addition, there was no significant difference in p53 overexpression between in situ and invasive areas of laryngeal carcinoma, thus no distinction has been made between these in recording the results. Dysplasia adjacent to invasive SCC (18 cases) also showed positive immunoreactivity.
A significant difference in p53 overexpression was observed between grade 1 dysplasia where only 30% (three of 10) of cases were positive and grades 2 and 3 where 75 (six of eight) and 60% (six of 10) positivity was observed (fig 2) . Although more cases were positive in grade 2 compared with grade 3 (75 v 60%) most of them (five of eight) showed positive immunoreactivity in less than 10% of cells. In grade 3 dysplasia four of eight cases showed diffuse immunoreactivity.
Although there was no linear correlation between the percentage of positive cells and the degree of smoking, all but three of the patients overexpressing p53 were smokers. All of those patients with grades 2 and 3 dysplasia with varying degrees of p53 immunoreactivity smoked.
Discussion
In this retrospective study of 83 Greek patients with laryngeal premalignant changes and invasive SCC of the larynx marked p53 overexpression (78%) was observed regardless of histological grade. As follow up was available for three years only and no reported deaths or lymph node metastases were reported in these patients during that time, the results have not been correlated with stage or survival but with histological grade and smoking habit.
To our knowledge, this is the first study to address the phenomenon ofp53 overexpression in laryngeal dysplasia without adjacent invasive malignancy and our results indicate a distinct difference between mild dysplasia where only 30% positivity was observed compared with grade 2 and 3 dysplasia (75% and 60%, respectively). We did not observe the same pattern of homogeneity in p53 expression in staining of normal epithelial nuclei adjacent to invasive SCC, as reported by Dolcetti et al, 22 and this may be because of the different immunohistochemical methods used to detect p53 overexpression, or the variable length of laryngectomy specimen fixation. In the same study frequent expression of p53 protein was observed in dysplasia adjacent to invasive SCC but the extent of p53 expression in relation to the histological grade of dysplasia was not reported. We confirmed previous reports that p53 overexpression is an early phenomenon in laryngeal carcinogenesis22 with clonal expansion of p53 positive cells during the sequential stages of laryngeal carcinogenesis, a phenomenon that may be advantageous to the malignant cells for tumour progression. We did It was impossible to demonstrate p53 protein expression reliably using the Streptavidin/ horseradish peroxidase method without pretreatment in a microwave oven. 24 Intensity of staining varied in the same section, particularly in the laryngectomy specimens, possibly due to the length of fixation which is important for the detection of p53 overexpression." Both antibodies gave comparable results with D07 being slightly more sensitive.28 Most of the patients included in this study were heavy smokers, confirming an association between p53 overexpression and heavy smoking although three non-smokers with invasive SCC of the larynx overexpressed the p53 protein.
We did not find any association between the histological grade of carcinomas and confirmed other reports that p53 overexpression is common in SCC of the larynx.
Other studies indicate that high frequency p53 gene alterations are associated with p53 overexpression, a finding supporting the hypothesis that tobacco carcinogens may contribute to the inactivation of the p53 tumour suppressor gene and although this phenomenon may be an early event in carcinogenesis it is not necessarily related to aggressive biological behaviour as has been shown in breast adenocarcinoma.2930 Apart from tobacco smoking, several aetiological factors have been implicated in laryngeal carcinogenesis. The role of HPVs in laryngeal carcinogenesis has not been clarified and it will be interesting to assess HPV positivity in laryngeal SCC as the virus binds the p53 protein, through the E6 region, with subsequent protein degradation.283' Mutations in the p53 gene have also been observed in animals with formaldehyde induced malignant tumours of the upper respiratory tract.32 Further studies are therefore required to assess the significance of early p53 overexpression in laryngeal carcinogenesis, and its premalignant role and invasive potential.
